Breast Cancer
A Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients with HER2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Plus Trastuzumab Plus Bevacizumab
Trial ID: 07119
Contact: Sharon S Ambro
Phone: (972)841-8345
Learn More about this trial.
go back | new search